Alumni raised $1.45B in 2022 - Download Free Report Now

ADispell

Fast-track development of novel drugs for an unmet medical need - Alzheimer\'s disease - with rapid payback on investment.

Start Free Trial
Claim Company Profile

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of ADispell plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About ADispell

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More

Companies We Work With

  • 0-Minnetronix.jpg
  • 1-jnj.png
  • 2-medtronic.png
  • 3-abbott.png
  • 4-baxter.png
  • 7-bostonscientific.png
  • 8-bd.png
  • 9-smithnephew.png
  • 10-stryker.png
  • 33m.png
  • allergan.jpg
  • bain.jpg
  • bbraun.png
  • beckmancoulter.png
  • cardinal.png
  • depuysynthes.png
  • drager.png
  • edwardslifesciences.png
  • ethicon.png
  • ge.png
  • gore.png
  • hospira.png
  • jlabs.jpg
  • kimberlyclark.png
  • merck.jpg
  • olympus.png
  • orthofix.png
  • philips.png
  • sanofigenzyme.png
  • teleflex.jpg
  • terumo.png
  • zimmerbiomet.png